X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8649) 8649
Publication (1095) 1095
Newsletter (512) 512
Book Review (260) 260
Newspaper Article (252) 252
Book / eBook (106) 106
Book Chapter (105) 105
Magazine Article (36) 36
Trade Publication Article (31) 31
Conference Proceeding (20) 20
Dissertation (19) 19
Report (4) 4
Web Resource (4) 4
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6202) 6202
hiv (4098) 4098
index medicus (4022) 4022
hiv infections - drug therapy (3820) 3820
pharmacology & pharmacy (2731) 2731
female (2678) 2678
male (2518) 2518
antiviral agents (2170) 2170
adult (2079) 2079
infectious diseases (2026) 2026
human immunodeficiency virus--hiv (2010) 2010
drug therapy (1747) 1747
anti-hiv agents - therapeutic use (1700) 1700
hiv infection (1699) 1699
pharmacokinetics (1653) 1653
antiretroviral therapy (1611) 1611
aids (1506) 1506
antiretroviral drugs (1363) 1363
middle aged (1360) 1360
hiv-1 - drug effects (1359) 1359
human-immunodeficiency-virus (1264) 1264
anti-hiv agents - pharmacokinetics (1226) 1226
protease inhibitors (1193) 1193
animals (1174) 1174
highly active antiretroviral therapy (1153) 1153
health aspects (1131) 1131
research (1112) 1112
hiv infections - virology (1089) 1089
virology (1068) 1068
anti-hiv agents - administration & dosage (1052) 1052
drug interactions (1035) 1035
immunology (1011) 1011
drug therapy, combination (998) 998
analysis (888) 888
hiv-1 (879) 879
anti-hiv agents - pharmacology (863) 863
therapy (848) 848
anti-hiv agents - adverse effects (803) 803
viral load (803) 803
infection (798) 798
treatment outcome (791) 791
reverse transcriptase inhibitors - therapeutic use (790) 790
microbiology (772) 772
tenofovir (770) 770
human immunodeficiency virus (734) 734
acquired immune deficiency syndrome--aids (729) 729
efavirenz (719) 719
reverse transcriptase inhibitors - pharmacokinetics (707) 707
drugs (665) 665
ritonavir (664) 664
hiv patients (654) 654
dosage and administration (651) 651
anti-hiv agents (644) 644
virus diseases (644) 644
drug resistance (634) 634
reverse-transcriptase inhibitors (629) 629
care and treatment (627) 627
hiv infections - complications (626) 626
zidovudine (622) 622
pharmacology (576) 576
antiretroviral therapy, highly active (573) 573
hiv protease inhibitors - therapeutic use (573) 573
article (571) 571
medicine & public health (567) 567
infections (551) 551
risk factors (542) 542
immunodeficiency-virus type-1 (541) 541
nevirapine (537) 537
safety (536) 536
adolescent (532) 532
active antiretroviral therapy (527) 527
cd4 lymphocyte count (521) 521
clinical trials (520) 520
hiv-infected patients (520) 520
in-vitro (518) 518
pregnancy (508) 508
reverse transcriptase inhibitors - administration & dosage (496) 496
research article (495) 495
hiv-1 - genetics (494) 494
drug resistance, viral (484) 484
chemistry, medicinal (478) 478
reverse transcriptase inhibitors - pharmacology (478) 478
medicine (475) 475
prevention (467) 467
adenine - analogs & derivatives (463) 463
lamivudine (451) 451
hiv protease inhibitors - pharmacokinetics (446) 446
resistance (444) 444
viruses (443) 443
medical research (434) 434
antiretroviral agents (433) 433
pharmacology/toxicology (424) 424
young adult (421) 421
mutation (420) 420
hiv infections - prevention & control (417) 417
internal medicine (417) 417
proteases (417) 417
hiv infections - metabolism (416) 416
aids/hiv (415) 415
child (414) 414
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (83) 83
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (5) 5
Credit Valley Hospital - Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Providence Healthcare - Reference (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9599) 9599
Spanish (47) 47
French (24) 24
German (10) 10
Japanese (6) 6
Italian (3) 3
Portuguese (2) 2
Russian (2) 2
Czech (1) 1
Dutch (1) 1
Persian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the International AIDS Society, ISSN 1758-2652, 01/2013, Volume 16, Issue 1, pp. 1 - n/a
Introduction Human immunodeficiency virus (HIV) type‐1 non‐nucleoside and nucleoside reverse transcriptase inhibitors (NNRTIs) are key drugs of highly active... 
nevirapine | delavirdine | non‐nucleoside reverse transcriptase inhibitors | next‐generation non‐nucleoside reverse transcriptase inhibitors | human immunodeficiency virus | etravirine | efavirenz | rilpivirine | Next-generation non-nucleoside reverse transcriptase inhibitors | Non-nucleoside reverse transcriptase inhibitors | Nevirapine | Rilpivirine | Etravirine | Human immunodeficiency virus | Efavirenz | Delavirdine | LERSIVIRINE UK-453,061 | STEADY-STATE PHARMACOKINETICS | INFECTIOUS DISEASES | next-generation non-nucleoside reverse transcriptase inhibitors | EXPERIENCED HIV-1-INFECTED PATIENTS | POSITIONAL ADAPTABILITY | SINGLE-DOSE PHARMACOKINETICS | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | TREATMENT-NAIVE | non-nucleoside reverse transcriptase inhibitors | IMMUNODEFICIENCY-VIRUS TYPE-1 | DOUBLE-BLIND | ANTIVIRAL ACTIVITY | Humans | Drug Discovery - trends | HIV Reverse Transcriptase - pharmacokinetics | HIV Reverse Transcriptase - pharmacology | HIV Infections - drug therapy | Treatment Outcome | Drug Approval | Antiretroviral Therapy, Highly Active - methods | HIV Reverse Transcriptase - adverse effects | Highly active antiretroviral therapy | Usage | Reverse transcriptase inhibitors | Research | Drug therapy | HIV infection | Health aspects | Antiretroviral drugs | Viruses | FDA approval | Mutation | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2009, Volume 50, Issue 5, pp. 482 - 491
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 7/2014, Volume 31, Issue 7, pp. 1834 - 1845
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2016, Volume 59, Issue 17, pp. 7991 - 8007
We designed and synthesized a series of human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a... 
BEARING BRIDGEHEAD NITROGEN | CHEMISTRY, MEDICINAL | ENTRANCE CHANNEL | MUTANT VIRUSES | ENHANCED SOLUBILITY | PRELIMINARY SAR | COLORIMETRIC ASSAY | BIOLOGICAL EVALUATION | NNRTI BINDING POCKET | CRYSTAL-STRUCTURES | ETRAVIRINE TMC125 | Anti-HIV Agents - pharmacology | Pyrimidines - chemical synthesis | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Drug Resistance, Viral | Reverse Transcriptase Inhibitors - pharmacology | Male | Structure-Activity Relationship | Anti-HIV Agents - chemical synthesis | Pyrimidines - chemistry | Reverse Transcriptase Inhibitors - chemistry | Reverse Transcriptase Inhibitors - chemical synthesis | Reverse Transcriptase Inhibitors - pharmacokinetics | Sulfonamides - chemistry | Heterocyclic Compounds, 2-Ring - chemistry | Thiophenes - pharmacology | Heterocyclic Compounds, 2-Ring - pharmacokinetics | Pyrimidines - pharmacology | HIV-1 - genetics | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Sulfonamides - pharmacokinetics | Heterocyclic Compounds, 2-Ring - pharmacology | Sulfonamides - chemical synthesis | Thiophenes - chemical synthesis | Thiophenes - pharmacokinetics | Anti-HIV Agents - chemistry | Animals | Anti-HIV Agents - pharmacokinetics | Cell Line, Tumor | Pyrimidines - pharmacokinetics | HIV-1 - enzymology | Mice | Molecular Docking Simulation | Mutation | Thiophenes - chemistry | Heterocyclic Compounds, 2-Ring - chemical synthesis
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2006, Volume 325, Issue 1, pp. 82 - 89
Journal Article
Journal Article
Journal Article
HIV Medicine, ISSN 1464-2662, 11/2008, Volume 9, Issue 10, pp. 883 - 896
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2009, Volume 50, Issue 5, p. 482
  Small intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot identify the range of factors that influence drug exposure in... 
Studies | Demographics | Womens health | Human immunodeficiency virus--HIV | Pharmacology | Drug therapy | Multivariate analysis
Journal Article